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Neutrophils have a dual aﬀect on epithelial pIgR/SC, the critical receptor for transcellular routing of mucosal IgA, but mechanisms
of pIgR/SC upregulation remain elusive. Requirements of cytokine, redox, and signalling pathways for pIgR/SC production were
assessed in human bronchial epithelial (Calu-3) cells cocultured with increasing numbers of blood neutrophils. Increased SC
production was observed after incubation for 48hrs with intermediate neutrophil numbers (1.25 to 2.5 × 106), was favoured
by the elastase inhibitor SLPI, and correlated with increased TGF-β production. Exogenous TGF-β stimulated SC production
with a maximal eﬀect at 48hrs and both TGF-β- and neutrophil-driven SC upregulation were dependent on redox balance and
p38 MAP-kinase activation. This paper shows that activated neutrophils could upregulate epithelial pIgR/SC production through
TGF-β-mediated activation of a redox-sensitive and p38 MAPK-dependent pathway. An imbalance between the two neutrophil-
driven opposite mechanisms (SC upregulation and SC degradation) could lead to downregulation of pIgR/SC, as observed in
severe COPD.
1.Introduction
The mucosal surfaces lining the respiratory tract are con-
tinuously exposed to potentially infectious agents, as well as
environmentaltoxicsandantigens.Thebronchialepithelium
acts as a physicochemical barrier of the airway mucosa
and is able to initiate inﬂammatory responses by releasing
mediators upon exposure to stimuli such as cigarette smoke-
or pathogen-derived molecules. One ﬁrst-line mechanism
of the airway immune defense against inhaled antigens
and microorganisms consists of secretory immunoglobulin
A (SIgA), the predominant immunoglobulin isotype in
mucosal secretions [1, 2]. In the lamina propria, mucosal
plasma cells produce IgA molecules mainly as polymers,
linked through a joining chain. Polymeric IgA (pIgA) then
binds to the polymeric Ig receptor (pIgR), a transmembrane
glycoprotein selectively expressed on the basolateral surface
of epithelial cells. The pIgA-pIgR complexes are transported
across epithelial cells up to the apical membrane where a
proteolyticcleavagereleasesthemainpartoftheextracellular
domain of pIgR, known as secretory component (SC),
remaining bound to pIgA to form SIgA [3] which assumes
protective, antiinfectious functions within the mucosal
lumen.
Chronic obstructive pulmonary disease (COPD) rep-
resents the fourth leading cause of death worldwide and
results in large consumption of health care resources [4].
This disorder characterized by progressive and mostly
irreversible limitation of expiratory airﬂow [5] is mainly
caused by cigarette smoking, whereas only some (15–
20%) smokers will develop the disease. Among features
of COPD are epithelial changes (mucous hyperplasia)
and chronic inﬂammation with recruitment/activation of
leukocytes including neutrophils, macrophages, and CD8+
T cells [6]. However, the links between airway neutrophilic
inﬂammationandimpairmentofepithelialfunctionsremain
poorly understood in COPD. We previously showed that
expression of pIgR/SC was strongly decreased in the
bronchial epithelium from patients with severe COPD, and
that this epithelial defect correlated with airﬂow limitation
and with inﬁltration of submucosal glands by neutrophils
[7].2 Journal of Biomedicine and Biotechnology
Neutrophils can be involved in various lung disor-
ders notably through the release of oxidants, proteinases
(including serine proteinases) and defensins, which have
important eﬀects on several epithelial functions such as
mucus secretion, cytokine release, or receptor expression.
More speciﬁcally, we next showed that activated neutrophils
can induce in vitro a cleavage of epithelial pIgR/SC through
the release of serine proteinases (particularly neutrophil elas-
tase), whereas a stimulatory eﬀect on pIgR/SC production
by cultured bronchial epithelial cells was also observed [8].
However, the mechanisms regulating this opposite eﬀect of
neutrophils on pIgR/SC expression in airway epithelial cells
remainunclear,inparticularfactorsresponsibleforincreased
pIgR/SC synthesis upon stimulation by neutrophils are not
identiﬁed.
The aim of the present work was therefore to evaluate the
molecular determinants of the “dual eﬀect” of neutrophils
on pIgR/SC expression in human bronchial epithelial cells.
More particularly, the involvement of soluble mediators
in the epithelial pIgR/SC upregulation by neutrophils was
investigated, as well as the role of proteinase/antiproteinase
and redox balances and of intracellular MAPKinase signaling
pathways.
2.MaterialsandMethods
2.1. Cell Cultures. Calu-3, a human (adenocarcinoma)
bronchial epithelial cell line, was obtained from the ATCC
(Rockville, MD), and cultured in RPMI-1640 supplemented
with 10% decomplemented fetal bovine serum, 100IU/ml
penicillin, 100μg/ml streptomycin and 2mM L-glutamine
(Cambrex, Rockland, ME) and referred to as “complete
medium”. 96-well plates were precoated for 2hrs at 37
◦C,
with 3.1μg/ml vitrogen (Cohesion, Palo Alto, CA), 10 μg/ml
ﬁbronectin, and 50μg/ml bovine serum albumin in RPMI
and followed by two washes with RPMI. To obtain a
conﬂuent bronchial epithelial layer, 50,000 Calu-3 cells were
seeded in this 96-well plate in 200μlo fc o m p l e t em e d i u m
and cultured for 5–7 days until conﬂuence.
Polymorphonuclearneutrophilswereobtainedfromwhole
heparinized blood from healthy donors by a one-step
density gradient method (40min centrifugation, 800×g,
room temperature)using Polymorphprep (Axis Shield, Oslo,
Norway) following manufacturer’s protocol. After washing,
neutrophils were resuspended in RPMI-1640 and activated
by 20 ng/ml IL-8 (R&D System, Minneapolis, MN) for 5 min
followed by 1nM formyl-Methionyl-Leucyl-Phenylalanine
(fMLP) (Sigma Aldrich, Saint Louis, MO) for 30min at 37
◦C
[8].Inallexperiments,IL-8/fMLPactivatedneutrophilswere
represented by “activated neutrophils”.
2.2. Cell Stimulation. Activated neutrophils alone were incu-
bated (from 1.25 to 5 × 106 cells) in complete medium for
48hrs to determine the production of cytokines including
TGF-β1 in supernatants.
Conﬂuent Calu-3 bronchial epithelial cells were cul-
tured for 48hrs, with or without TGF-β1 (20ng/ml, R&D
System). To evaluate the dose response to TGF-β1, cells
were incubated with increasing concentration from 0.2 to
80ng/ml. After culture, pIgR/SC production was measured
in supernatants and cell lysates.
Calu-3/neutrophils coculture. To analyse the dose–
responseeﬀectofneutrophilsonSCproductionbybronchial
epithelial cells, conﬂuent monolayers of Calu-3 cells were
incubated for 48hrs with increasing numbers of activated
neutrophils (from 0.3 to 15 × 106 cells) in the presence or
not of 2.5μM human Secretory Leukocyte Protease Inhibitor
(SLPI, R&D system).
Kinetics (from 2 to 72hrs) of TGF-β1p r o d u c t i o nb y
Calu-3 epithelial monolayers alone, activated neutrophils
(5 × 106 cells) alone or bronchial epithelial cells cocultured
with neutrophils was also analyzed. Similarly, kinetics (from
1 to 48hrs) of SC secretion by Calu-3 epithelial layers
was measured after incubation with TGF-β-1 (20ng/ml) or
activated neutrophils (5 ×106 cells).
At the end of each culture, the required volume of
supernatantwastakentomeasureelastaseenzymaticactivity,
and 2mM Phenylmethylsulfonyl ﬂuoride (PMSF, Sigma
Aldrich) was then added to inhibit further serine proteinase
activity. Supernatants were harvested and frozen at −20
◦C
until SC titration. Epithelial cells were washed twice in PBS
andlysedwith100μlTriton(SigmaAldrich)0.1%w/vinPBS
for 15min on ice. Cell lysates were harvested and frozen at
−20
◦C until SC titration.
Independentexperimentsrepresentresultsfromdiﬀerent
neutrophil donors.
2.3. Cytotoxicity Assay. Cell viability and activity of mito-
chondrial electron transport chain, as indicator for cyto-
toxicity, was determined by the capacity of cells to reduce
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) to formazan [9]. Conﬂuent Calu-3 epithelial
cells were incubated with increasing number of neutrophils
(from 0.3 to 15 × 106), with increasing concentrations
of TGF-β (from 0.2 to 80ng/ml), with CSE (from 0.1%
to 10%) and with MAPKinases inhibitors (PD, SP, and
SB) for 48hrs. After incubation, cells were washed with
PBS. 100μl of PBS containing 1mg/ml MTT was added
to each well and the plate was returned to 37
◦C. After
1h, the medium was removed by ﬂicking oﬀ. To solubilize
intracellular formazan produced by active mitochondria in
living cells, 100μl of dimethylsulfoxide (DMSO) was added
per well. The absorbance at 550nm was measured on a
spectrophotometric plate reader and used for the calculation
of relative cell viability where untreated cells represented
100% viability.
2.4. ELISA for Human SC and TGF-β1. SC concentration
was determined in culture supernatants and cell lysates from
epithelial cells by sandwich ELISA, as previously reported
[8], by using aﬃnity puriﬁed goat antihuman SC polyclonal
antibody (developed in our laboratory, recognizing both
soluble SC and membrane pIgR/SC) as capture and detec-
tion (biotinylated) antibody. The reaction was revealed by
streptavidine-HRP followed by tetramethylbenzidine (TMB)
in the presence of hydrogen peroxide. OD were recorded atJournal of Biomedicine and Biotechnology 3
450nmusingamicroplatespectrometer(Biorad).Sensitivity
of the immunoassay was ∼0.2ng/ml.
TGF-β production was measured in supernatants from
Calu-3 cells, neutrophils or Calu-3/neutrophils cocultures by
ELISA.Astepofsampleextraction(acidiﬁcation)wascarried
out to allow for the release of TGF-β1f r o ml a t e n tc o m p l e x e s ,
making it accessible for measurement in the immunoassay. A
monoclonal antibody speciﬁc for TGF-β1h a db e e nc o a t e d
onto the wells and extracted samples and standards were
put into these wells followed by addition of biotinylated
secondary antibody (TGF-β immunoassay kit, Biosource,
Nivelles, Belgium). The sensitivity of TGF-β1 immunoassay
was 15.6pg/ml.
2.5. Determination of Neutrophil Elastase Activity.
Neutrophil elastase activity was measured in epithelial
cell/neutrophilscoculturesupernatants.N-methoxysuccinyl-
ala-ala-pro-val-p-nitroanilide (Sigma Chemical) was used as
speciﬁc substrate, diluted at 1mM in 0.1M HEPES buﬀer,
pH 7.5, with 0.5M NaCl and 10% v/v dimethylsulfoxide.
Supernatants (50μl) were incubated with 100μlo fs u b s t r a t e
solution at 37
◦C in 96-well plates, and OD increase was
monitored at 415nm using a microplate reader (Biorad).
Results were compared with standard curves obtained
with serial dilutions of puriﬁed neutrophil elastase (Elastin
products Co., Owensville, MA), and expressed in nmole/l.
2.6. Analysis of Redox Changes. Conﬂuent bronchial epithe-
lial layers were incubated for 48hrs with TGF-β1( 2 0n g / m l )
or with PMN (5 × 106) in the presence of the antioxidants
N-acetylcysteinorglutathione(Sigma)atﬁnalconcentration
of 10mM. The production of SC was measured in super-
natants.
2.7. Western Blot Analysis of MAPKinases. After 30min of
stimulation by TGF-β of a conﬂuent monolayer in a 12-well
plate,Calu-3cellswerelyzedin150μlofRIP Abuﬀer[16mM
Trisbase,150mMNaCl,6mMEDTA,10gNonidet(NP-40),
12mM sodium deoxycholate, 3mM SDS, and pH 7.4] with
10μg/ml of protease cocktail inhibitor (Roche), 1mM PMSF,
1mM NaF and 1mM Na3VO4. 40μl of protein lysate are
diluted in 40μl of Laemmli’s sample buﬀer, heated at 100
◦C
for 5min, loaded in a 12% SDS-PAGE gel and run at 180V
for 1h. Cell proteins were transferred onto a nitrocellulose
membrane (Hybond-C, Amersham Biosciences, UK) at
70mA for 1.5h at room temperature. The membrane was
blocked with 5% BSA in Tris-buﬀered saline with 0.1%
Tween 20 (TBST) for 1h at room temperature, washed, and
incubated with the primary Ab diluted 1/1000 in TBST-BSA
1% (anti-phospho ERK, anti-phospho p38 or anti-phospho
JNK; Cell signalling Technology, Beverly, MA) overnight
at 4◦C. Membranes were then incubated for 1h at room
temperature with a secondary Ab diluted 1/2000 in TBST-
BSA 1% (anti-rabbit IgG/HRP, Cell signalling Technology).
Immunoreactive bands were developed using chemilumi-
nescence (ECL, Amersham Biosciences, UK) and detected
with the Chemidoc XRS apparatus (Bio-Rad Laboratories,
Hercules, CA).
2.8.MAPKinaseInhibitionAssay. Calu-3epithelialcellswere
pretreated for 1hr with 50μM PD98059, 50μM SB203580
or 50μM SP600125 as selective inhibitors of extracellular
signal-regulatedkinase-1/2(ERK)mitogen-activatedprotein
kinase (MAPK), p38 MAPK, and c-jun-N-Terminal Kinase
(JNK) MAPK, respectively (New England Biolabs, Beverly,
MA). Calu-3 cells were then incubated for 48hrs with TGF-
β1 (20ng/ml) or neutrophils (5 × 106 cells), and production
of SC in supernatants was determined by ELISA.
2.9. Statistical Analysis. Results were expressed as mean ±
SEM, unless otherwise stated. The diﬀerences between the
groups were analyzed as appropriate by means of the Mann
Whitney test, using Graphpad Prism 4.0 (Graphpad Prism,
SanDiego,CA).P values<. 05wereconsideredasstatistically
signiﬁcant.
3. Results
3.1. Neutrophils Have a Dual Eﬀect on pIgR/SC Production.
To set up a model to examine eﬀects of neutrophils on SC
production by bronchial epithelial cells, conﬂuent epithelial
layers of Calu-3 cells were incubated for 48hrs with increas-
ing numbers of activated neutrophils (Figure 1(a)), with
evaluation of cytotoxicity. Neutrophil concentrations from
0.3 × 106 to 5 × 106 did not signiﬁcantly aﬀect epithelial cell
viability according to MTT assay (viability ≥ 80% compared
tocontrol).Howevercytotoxicitywasobservedfor ≥ 10×106
neutrophils (cell viability decreased by ∼20%).
SC production increased when epithelial cells were
incubated with neutrophils, starting at 1.25 × 106 and
with a maximal increase at 2.5 × 106 neutrophils (P<
.01, Figure 1(a)). At further increased neutrophil numbers
(> 5×106),SCproduction wasdownregulated and tendedto
decrease at 15×106 neutrophils as compared to control (P =
.08, Figure 1(a)), consistent with cytotoxicity (MTT assay)
and/or proteolytic cleavage [8]. Elastase activity evaluated in
supernatants from the same Calu-3/neutrophils cocultures
increased as expected with the number of neutrophils
(Figure 1(b)). These results indicated that this system
allowed to address the two opposite eﬀects of neutrophils on
epithelial SC, and experiments were carried out to explore
the mechanisms of SC upregulation by “nontoxic” numbers
ofneutrophilsreleasingelastaseinaconcentrationrangethat
could be observed in chronic airway neutrophilic diseases,
for example, during exacerbations.
3.2. Neutrophil-Driven SC Upregulation Is Modulated by
Serine Proteinase Activity. To evaluate the role of ser-
ine proteinases on the regulation of SC production by
neutrophils, Calu-3 cells were cultured with increasing
neutrophil numbers in the presence or not of secretory
leukocyte protease inhibitor (SLPI), a natural inhibitor
of neutrophil elastase, at a concentration (2.5μM) almost
completely suppressing elastase activity (>90% inhibition).
SC production was measured in both epithelial supernatants
and cell lysates (Figure 2). In the presence of exogenous
SLPI, SC upregulation observed in epithelial supernatants4 Journal of Biomedicine and Biotechnology
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Figure 1: Dual eﬀect of neutrophils on SC secretion. Conﬂuent monolayers of Calu-3 cells were incubated in triplicates for 48hrs with
increasing numbers of neutrophils, from 0.3 × 106 to 15 × 106 cells. (a) SC concentration and (b) elastase activity were measured in
supernatants, as described in Methods. Data are means ± SEM (n = 6 independent experiments). #P = .08, ∗P ≤ .05 and ∗∗P ≤ .01
as compared with control.
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Figure 2: Eﬀect of Secretory Leucoproteinase Inhibitor (SLPI) on
pIgR/SC production. Conﬂuent Calu-3 monolayers were cultured
with increasing numbers of neutrophils (0.6 × 106 to 10 × 106 cells)
in the presence (dashed line) or in the absence (full line) of SLPI.
After 48hrs, SC production was measured in supernatants (black
lines) and in cell lysates (grey lines). Data are means ± SD of one
experiment (out of 2) in triplicates. ∗P ≤ .05 as compared with
control.
at intermediate neutrophil numbers (P<. 05 at 2.5 × 106
neutrophils) was further increased. In addition, the presence
of SLPI promoted an increase in pIgR/SC in epithelial lysates
(P<. 05 at 0.6 × 106 neutrophils), while no eﬀect was
observed in this cell compartment in the absence of SLPI
(Figure 2) or with SLPI alone, without neutrophils (data not
shown).
3.3. TGF-β Is Increased upon Coculture of Calu-3 Cells with
Neutrophils. Besides the eﬀect of proteinases/antiproteinases
onSCupregulation,involvementofotherneutrophil(and/or
epithelial)-derived soluble factors was assessed. Cytokines
known to induce pIgR transcription such as TNF-α or
IL-1β were not detected in coculture supernatants (data
not shown). In contrast, TGF-β, which was detected in
resting Calu-3 cell supernatants at a similar level as in
complete (serum-supplemented) medium, was increased
upon neutrophil coculture (∼3-fold increase at 5 × 106
neutrophils, P<. 05; Figure 3(a)).
Inordertodeterminetherespectiveroleofepithelialcells
and neutrophils in TGF-β production, a time course of TGF-
β production by epithelial cells alone, activated neutrophils
alone or epithelial cell/neutrophil cocultures was carried out
(Figure 3(b)). A trend for TGF-β increase was observed in
neutrophil and coculture supernatants as early as after 2hrs,
and further increased at later time points (P<. 05 at 48
and 72hrs, Figure 3(b)) in cocultures. In contrast, epithelial
cells began to secrete TGF-β between 48–72hrs, with a 3-
fold increase as compared to 2hrs (P<. 0 5 ) .A te a c ht i m e
point, TGF-β in neutrophil supernatants was higher than
the epithelial production, except at 72hrs. These results
indicated that neutrophils represented the main source of
TGF-β up to 48hrs of coculture, with a modest (and late)
contribution from epithelial cells.
3.4. TGF-β Upregulates Epithelial pIgR/SC Production. TGF-
β was then evaluated for a potential eﬀect on pIgR/SC
production. TGF-β had no signiﬁcant cytotoxic eﬀect on
epithelial cell viability up to 80ng/ml, with even increased
MTT reduction at 80ng/ml (not shown). Addition of
recombinanthumanTGF-β1signiﬁcantlyincreasedpIgR/SC
production, in cell lysates (P<. 05; Figure 4(a)), and a
trend was also observed for SC secretion in supernatants.Journal of Biomedicine and Biotechnology 5
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Figure 3: TGF-β1 production in epithelial/neutrophil cocultures. (a) TGF-β1 production was measured by ELISA in supernatants of Calu-3
cells incubated for 48hrs with increasing numbers of neutrophils (1.25 × 106 to 5 × 106 cells). (b) Kinetics (from 2 to 72hrs) of TGF-
β1 production by Calu-3 cells alone (open bars), neutrophils alone (5 × 106 cells, stripped bars) or epithelial cell/neutrophil cocultures
(5 × 106 neutrophils, solid bars). The horizontal bar represents TGF-β1 concentration in complete medium, containing fetal calf serum
(201 ± 40pg/ml, mean ± SD, n = 3). Data are means ± SEM (n = 4 independent experiments, both for a and b). (a) ∗P ≤ .05 as compared
with control; (b) ∗P ≤ .05 as compared with Calu-3 alone, #P ≤ .05 as compared with Calu-3 at 2hrs.
In dose-response experiments, SC production upon TGF-
β stimulation increased from 1ng/ml to reach a plateau
∼20ng/ml (Figure 4(b)). The kinetics of SC production
by bronchial epithelial cells incubated with TGF-β or
neutrophils, the main source of TGF-β, was assessed
(Figure 4(c)). From 1hr to 14hrs of incubation, no diﬀer-
ence was observed between the three conditions of stimu-
lation, constitutive SC production starting to signiﬁcantly
increase from 24hrs. Eﬀects of TGF-β and neutrophils
had similar kinetics on SC production, with upregulation
observed at 48hrs (Figure 4(c)).
3.5. SC Upregulation by TGF-β and Neutrophils Depends on
the Redox Balance. We examined whether the redox balance
could aﬀect TGF-β- and neutrophil-induced SC upregula-
tion. Calu-3 cells were cultured with TGF-β or neutrophils
in the presence or not of two antioxidants, N-acetylcysteine
and glutathione. In the presence of these antioxidants,
eﬀects of neutrophils were inhibited, with a trend for TGF-
β (Figure 5(a)). N-acetylcysteine and glutathione had no
eﬀect on TGF-β production, whereas they did slightly reduce
elastase activity presumably by reducing the pH (data not
shown).
The link between p38 MAPK activation and redox bal-
ance in epithelial cells cocultured with activated neutrophils
wasassessed.Activationofp38andERKwasassayedinCalu-
3 cells cocultured with neutrophils in the presence or not
ofN-acetylcysteine(Figure 5(b)).Uponneutrophilcoculture
ERK was activated at 60min, while p38 was activated as soon
as after 5min and also peaked at 60min. In the presence of
theantioxidant,p38MAPKactivationwasinhibited,whereas
that of ERK was not aﬀected or even promoted.
3.6. SC Upregulation by TGF-β and Neutrophils Depends on
p38 MAPK Activation. To analyse the intracellular mecha-
nisms involved in SC upregulation and engaged in bronchial
epithelial cells activated by TGF-β or neutrophils, activation
of ERK, p38, and JNK MAPKinase was assessed, as well
as eﬀects of their selective inhibition. For each inhibitor,
speciﬁcity and absence of signiﬁcant cytotoxicity was con-
ﬁrmed by western blot and MTT assay, respectively (data not
shown). Activation of ERK and p38 MAPK was conﬁrmed in
Calu-3 stimulated by TGF-β, with a maximal eﬀect at 5min
both for ERK and p38 (Figure 6(a)).
The pharmacologic inhibitors did not signiﬁcantly aﬀect
baseline SC secretion (Figure 6(b)). While no signiﬁcant
eﬀects were observed with ERK or JNK pathway inhibitors
(PD98059 and SP600125, resp.), the p38 MAPK inhibitor
(SB203580) suppressed neutrophil- and TGF-β-driven SC
upregulation (P<. 05, Figure 6(b)).
4. Discussion
EpithelialpIgR/SCisthecriticalreceptorforthetranscellular
routing of IgA involved in frontline defense mechanisms
at mucosal surfaces, including the airways. We previously
observed that the bronchial epithelium of severe COPD
displays a strongly reduced pIgR/SC expression, which cor-
related with airway obstruction and neutrophil inﬁltration
[7]. Our previous in vitro study showed that neutrophils
could induce on one hand pIgR/SC cleavage and on the
o t h e rh a n du p r e g u l a t i o no fS Cp r o d u c t i o ni ne p i t h e l i a lc e l l s
[8], suggesting a “dual eﬀect” of neutrophils on pIgR/SC.
This study shows that, in an in vitro coculture system set
up to address the mechanisms of pIgR/SC dual regulation by6 Journal of Biomedicine and Biotechnology
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Figure 4: Eﬀe c to fT G F - β1 on pIgR/SC production. (a) Calu-3 cells were cultured for 48hrs with or without TGF-β1 (20ng/ml).
SC production was evaluated in supernatants (solid bars) and in cell lysates (open bars). (b) Calu-3 cells were exposed to increasing
concentration of TGF-β1 (0.2 to 80ng/ml) for 48hrs, and SC was measured in supernatants. (c) SC production was assessed in supernatants
from resting Calu-3 cells as control (open bars), Calu-3 cells incubated with TGF-β1 (20ng/ml, solid bars) and Calu-3 cells/neutrophil
cocultures (stripped bars) for 1hr to 48hrs. Results are expressed as means ± SEM for (a) (n = 7 independent experiments with triplicates),
(b) (n = 3) and (c) (n = 3). ∗P<. 05 as compared with control (a, b, c); #P<. 05 as compared with control at 1hr (c).
neutrophils,increasedepithelialSCproductionwasobserved
at intermediate numbers of neutrophils (corresponding to
∼10nM elastase released), while further increasing neu-
trophils downregulated SC, presumably due to proteolytic
cleavage (>20nM elastase; [8]) and/or cytotoxic eﬀects. In
addition, SC upregulation was favoured in the presence
of SLPI, a natural elastase inhibitor, and associated with
TGF-β production by neutrophils. Moreover, we show for
the ﬁrst time that TGF-β is able to stimulate epithelial
pIgR/SC production, in a dose-dependent manner. We
also demonstrate that TGF-β- and neutrophil-driven SC
upregulation depends on the redox balance (cigarette smoke
extracts and antioxidants both suppressing the eﬀect) and
that p38 MAP kinase represents a downstream, intracellular
signalling pathway targeted by TGF-β to induce pIgR/SC
production upon stimulation by neutrophils.
Neutrophils are able to secrete a large range of sol-
uble factors including proteinases and oxidants, as well
as cytokines/chemokines and growth factors, involved in
inﬂammatory responses and tissue remodelling. Among
these factors produced by neutrophils, our data indicate
that elastase and TGF-β represent the major candidates
to underlie, respectively, the down- and upregulation of
pIgR/SC in epithelial cells exposed to activated neutrophils.
Ar o b u s tp r o d u c t i o no fT G F - β was detected in our coculture
supernatants, mainly arising from neutrophils. In addition,Journal of Biomedicine and Biotechnology 7
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Figure 5: Eﬀe c to fr e d o xc h a n g e so nT G F - β and neutrophil-
induced SC production. (a) Calu-3 cells were incubated (or not,
as control) for 48hrs with TFG-β1 (20ng/ml) or neutrophils (5 ×
106 cells) in the presence or not of the antioxidants N-acetylcysteine
(NAC,10 mM, grey bars) or glutathione (GSH, 10mM, solid bars).
Supernatants were assayed for SC by ELISA. Data are means ± SEM
(n = 3). ∗P<. 05 as compared with control. (b) Calu-3 cells
were cocultured (in a 24-wells plate) with neutrophils (80 × 106
cells) in the presence or not of NAC (10mM) for 5 to 120min, and
phosphorylation of ERK1/2 and p38 was assayed by western blot, as
compared to β-actin as loading control.
a dose-dependent increase in SC expression was observed
upon exogenous TGF-β stimulation. TGF-β produced in
coculturesranged from ∼0.5 to 1ng/ml (Figure 3), a concen-
tration close to levels eﬀectively upregulating SC production
(Figure 4(b)). In addition, maximal SC production was
reached at 48hrs of stimulation, both for TGF-β and
neutrophils. Moreover, functional experiments pointed to
common molecular pathways (redox system, p38 MAPK),
further supporting that neutrophils could induce pIgR/SC
expression mainly by producing TGF-β.
While elastase is the major serine proteinase released
by neutrophils involved in lung tissue breakdown due to
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Figure 6: Eﬀect of MAP kinase inhibitors on pIgR/SC production.
(a) Calu-3 cells were cultured with TGF-β1( 2 0 n g / m l )f o r5t o
120min and phosphorylation of ERK1/2 and p38 was assayed by
w e s t e r nb l o t ,a sc o m p a r e dt oβ-actin as loading control. (b) Calu-
3 cells were cultured with TGF-β1 (20ng/ml) or neutrophils (5 ×
106 cells) for 48hrs in the presence of medium alone (control)
or MAP Kinase inhibitors: PD98059 (grey bars), SB203580 (solid
bars) or SP600125 (stripped bars) (all 50μM) as selective inhibitors
of ERK1/2 MAPK, p38 MAPK and JNK MAPK, respectively. SC
production was assessed in supernatants and results were shown as
means ± SEM (n = 4). ∗P<. 05, ∗∗P<. 01 as compared with
control.
cigarette smoking (know as “emphysema”), TGF-β repre-
sents a multifunctional growth factor. It modulates cell
proliferation and diﬀerentiation and induces synthesis of
extracellular matrix proteins [10, 11] and is thereby involved
in the development of tissue ﬁbrosis. TGF-β has also
been shown as chemotactic for neutrophils, while exerting
prominent immunosuppressive functions [12]. In addition,
it has a unique role in mucosal tissues in promoting class
switch recombination of mucosal plasma cells to IgA, a
critical Ig for prevention of microbial infection and for
control of the commensal ﬂora [13, 14]. Here, we show that
TGF-β not only triggers IgA synthesis but also promotes its
transport across the epithelium, further supporting the view
of this cytokine as a critical factor in mucosal homeostasis.
Bronchial epithelial cells can also produce TGF-β either
constitutively or upon stimulation such as by cigarette8 Journal of Biomedicine and Biotechnology
smoke [15, 16], whereas IFN-γ inhibits epithelial TGF-β
release whilst promoting pIgR/SC expression. Intriguingly,
it was shown that TGF-β expression is increased in small
airway epithelium from smokers and patients with COPD
[17, 18], and was suggested as a factor downregulating
SLPI expression in these patients [19]. A reduction in
SLPI secretion can also be induced by elastase, as recently
reported [20]. Of note, no production of SLPI (or elaﬁn)
was detected in our study using Calu-3 cells (data not
shown). Thus, it remains to investigate whether relation-
ships between TGF-β signalling and epithelial functions—
including production of pIgR/SC and SLPI—are aﬀected in
COPD.
In healthy subjects, a balance between oxidants and
antioxidants keeps the extracellular environment in a
reduced state. Cigarette smoke, which contains massive
amounts of oxidants, is the most important risk factor for
the development of COPD [21]. The major nonenzymatic
antioxidantofthelungisglutathione(GSH)[22].Ourresults
showed that glutathione or N-acetylcysteine, a glutathione
precursor, inhibited the epithelial SC production induced
by TGF-β or by neutrophils. TGF-β is produced in an
inactive form, complexed to the latency-associated peptide
(LAP), and this complex needs to be dissociated to release
active TGF-β. Reactive oxygen species (ROS) are able to
oxidize LAP and to release active TGF-β, this eﬀect being
prevented by oxidant scavenging [16]. The main cellular
sources of ROS in the lung not only include activated
phagocytes such as neutrophils but also structural cells
such as endothelial cells, alveolar and bronchial epithelial
cells [23, 24]. Accordingly, it is plausible that in our study
GSH and NAC prevented TGF-β activation by neutrophil
(or epithelial cell)—derived oxidants, thereby inhibiting
TGF-β—induced SC production. In addition, antioxidants
could also aﬀect epithelial intracellular signalling, includ-
ing p38 MAPK activation [25, 26]. Similarly, the natural
antiproteinaseSLPImightmodulateTGF-β-andneutrophil-
driven epithelial cell activation, such as NFκBp a t h w a y[ 27].
However, our data support that SLPI further promotes SC
upregulation upon neutrophil coculture not by aﬀecting
epithelial cell signalling but rather by inhibiting elastase
activity.
Intracellular kinases play a crucial role in the control
of activation of (anti)inﬂammatory genes in the airways, in
T-cell function and tissue remodelling. In particular, MAP
kinases control in airway epithelial cells the transcription
of several genes involved in COPD pathogenesis such as
mucins and inﬂammatory mediators (e.g., TNF-α,I L - 8 ,
and matrix metalloproteinases) [28]. Neutrophil- and TGF-
β-driven SC upregulation in epithelial cells was almost
completely abolished by the inhibitor SB203580, indicating
the requirement for p38 MAPK activation, in contrast to
ERK and JNK pathways. In human bronchial epithelial cells,
exposure to oxidants (peroxide) activates MAPK cascades,
particularly stress responsive p38 MAPK [25,o u rd a t a ] .
Thus, oxidative stress, caused by inﬂammatory cells and/or
by cigarette smoke derivatives may upregulate epithelial
pIgR/SC production by activating p38 MAPK. Increased
numbers of p38 positive cells were previously observed in
alveolar walls of patients with COPD, as compared to smok-
ers and nonsmoking controls [29]. Moreover, p38 inhibitors
are eﬀective in several animal models of inﬂammatory
disorders, including COPD [30]. For instance, the inhibitor
SB2439063 reduced neutrophilia and expression of inﬂam-
matory mediators in a rat model of COPD [31]. However,
it has been observed that cytokine-induced synthesis of
elaﬁn, another natural epithelial-derived neutrophil elastase
inhibitor, is also dependent on p38 MAPK [32, 33]. Thus,
activation of p38 MAPK pathway might be critical in the
airways to both inﬂammatory responses and transactivation
ofprotectiveepithelialgenes,includinglocalanti-proteinases
and pIgR/SC.
In conclusion, this paper demonstrates that activated
neutrophils trigger increased epithelial pIgR/SC expression
through redox- and p38 MAPK-dependent mechanisms.
It also highlights a novel mucosal function for TGF-β,
upregulating not only IgA synthesis but also its receptor-
mediated transepithelial transport, and further suggests that
the redox balance plays an important role in modulating
epithelial responses to neutrophils. Thus, this paper pro-
vides a molecular basis for the dual eﬀect of neutrophils
on mucosal/secretory immunity which consists of on the
one hand on proteolytic cleavage of pIgR/SC (and IgA)
by elastase and proteinase-3 [8], and on the other hand
on TGF-β-mediated activation of pIgR/SC synthesis via
oxidant- and p38-dependent pathways. These ﬁndings are
relevant to airway cell biology and neutrophilic airway dis-
eases, suggesting that imbalance between the two identiﬁed
opposite regulatory mechanisms of pIgR/SC may lead to
downregulation of secretory IgA immunity, as observed
in smokers who developed severe COPD [6]. The cellular
and molecular determinants of this (im)balance and ﬁne
tuning of pIgR expression will be further investigated in
primary cultures of airway epithelial cells from COPD
patients.
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